Monday, May 15, 2017
by Cara Lotspeich
BJC HOSPICE | Patrick White, MD, HMDC, FACP, FAAHPM, BJC Hospice chief medical officer, has been appointed by Gov. Eric Greitens as the first member of the inaugural Palliative Care and Quality of Life Interdisciplinary Council. This council will be tasked with finding ways to relieve pain, nausea and other common symptoms while improving quality of life in Missourians with serious illnesses.
The 11-member interdisciplinary committee will focus on expanding access to palliative care, which focuses on treatment of the whole person, including the physical and emotional effects related to the illness and its treatment.
Palliative care is often combined with curative therapies to help patients achieve their goals and objectives with the highest quality of life possible. A landmark study at one of Harvard’s teaching hospitals found that patients with advanced lung cancer receiving this form of care may have both lower levels of symptoms and actually live longer than those without access to palliative care. Other research studies have found patients receiving palliative care are more likely to complete their treatment course, and overall health care costs may be reduced by helping patients remain at home.
“It is an honor and privilege to give back to this community who has been so supportive of my mission,” Dr. White says. “I’m grateful for the educational support provided by the National Institutes of Health and the many dedicated physicians, nurses, social workers and chaplains who taught me the value of treating the whole person. I’m confident this interdisciplinary support will allow us to improve patient outcomes, increase satisfaction with care and reduce health care costs by implementing patient-centered care.”
Dr. White is part of the internal medicine faculty at Washington University and practices palliative care and internal medicine at Barnes-Jewish Hospital. He has previously won awards from the American Academy of Hospice and Palliative Medicine, Washington University, and the American College of Physicians for leadership, teaching excellence and community service. He is one of the first physicians in the United States to pursue a doctorate degree in comparative effectiveness research specifically examining therapies to relieve symptoms in patients with serious illness. Current studies include examining novel treatments to reduce pain in patients with painful bone metastases and determining optimal therapies to reduce nausea in patients with advanced cancer.
Dr. White is inaugural recipient of Delta Distinguished Scholar Award
BJC Hospice chief medical officer Patrick White, MD, is the first-ever recipient of the Delta Distinguished Scholar award. He received an initial $25,000 research grant for study into comparative and cost effectiveness of pharmaceuticals.
“Even if we can’t cure, there are ways to relieve symptoms,” says Dr. White, whose choice of hospice medicine came from his experience as a young child, when he visited patients with his father, a pulmonologist.
“Improving a cough or alleviating shortness of breath meant the world to those patients and their families,” he says. “Now, through the research initiated by this grant, my team and I have tremendous opportunity to reduce suffering and identify those most likely to benefit from particular drug therapies at end of life.”
Delta Care Rx is a leading pharmaceutical innovator in the field of hospice medicine. With about 1.5 million patients in the United States receiving hospice care, Dr. White’s research on symptom management and pain control could benefit many patients in the near future.
Pharmaceutical research is very limited with hospice medicine, as hospice patients are excluded from most clinical trials. This makes it difficult to determine which medicines are effective. Too often, physicians make choices based on cost, rather than effectiveness.
“Dr. White exemplifies the physician-researcher model and has a demonstrated interest in cost-effective medication use,” says Mary Mihaylo, Delta Care Rx CEO.
“Dr. White may be able to prove that newer medications are equally cost effective to those used historically, and that would be valuable information,” says Mihaylo. “He is distinguished by his commitment to take hospice and palliative medicine to a higher level of extreme, patient-focused care.”
“I am especially grateful this award came from Delta Care Rx,” says Dr. White. “They are an integral part of the effort to advance the cause of quality patient-centered care.”
Cara Lotspeich, firstname.lastname@example.org
Tags : Dr. Patrick White
Number of views (1403)/Comments (1)
5/22/2017 10:46 AM
Proud to be working along side Dr. White as we improve the care we provide by responding to what patients say they want and how they want to live their lives. That is the best medicine.